197 related articles for article (PubMed ID: 32669975)
1. Small nucleolar RNAs signature (SNORS) identified clinical outcome and prognosis of bladder cancer (BLCA).
Cao R; Ma B; Yuan L; Wang G; Tian Y
Cancer Cell Int; 2020; 20():299. PubMed ID: 32669975
[TBL] [Abstract][Full Text] [Related]
2. Small Nucleolar RNAs (snoRNAs)-Based Risk Score Classifier Predicts Overall Survival in Bladder Carcinoma.
He RQ; Huang ZG; Zhai GQ; Huang SN; Gu YY; Gu YY; Chen G; Ma J; Cheng JW; Yan HB; Li SH
Med Sci Monit; 2020 Oct; 26():e926273. PubMed ID: 33104528
[TBL] [Abstract][Full Text] [Related]
3. Integrative genomic analysis of a novel small nucleolar RNAs prognostic signature in patients with acute myelocytic leukemia.
Huang R; Liao X; Li Q
Math Biosci Eng; 2022 Jan; 19(3):2424-2452. PubMed ID: 35240791
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer.
Zhu K; Deng W; Deng H; Liu X; Wang G; Fu B
PPAR Res; 2021; 2021():7056506. PubMed ID: 35027921
[TBL] [Abstract][Full Text] [Related]
5. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
6. An EMT-related gene signature for the prognosis of human bladder cancer.
Cao R; Yuan L; Ma B; Wang G; Qiu W; Tian Y
J Cell Mol Med; 2020 Jan; 24(1):605-617. PubMed ID: 31657881
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel nine-SnoRNA signature with potential prognostic and therapeutic value in ovarian cancer.
Zhu W; Zhang T; Luan S; Kong Q; Hu W; Zou X; Zheng F; Han W
Cancer Med; 2022 May; 11(10):2159-2170. PubMed ID: 35187852
[TBL] [Abstract][Full Text] [Related]
8. An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA).
Cao R; Ma B; Wang G; Xiong Y; Tian Y; Yuan L
Dis Markers; 2020; 2020():8833972. PubMed ID: 33204364
[TBL] [Abstract][Full Text] [Related]
9. Identification of three small nucleolar RNAs (snoRNAs) as potential prognostic markers in diffuse large B-cell lymphoma.
Li MW; Huang FX; Xie ZC; Hong HY; Xu QY; Peng ZG
Cancer Med; 2023 Feb; 12(3):3812-3829. PubMed ID: 36812125
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
[TBL] [Abstract][Full Text] [Related]
11. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
[TBL] [Abstract][Full Text] [Related]
12. Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA).
Cao R; Yuan L; Ma B; Wang G; Tian Y
Cancer Cell Int; 2020; 20():276. PubMed ID: 32607061
[TBL] [Abstract][Full Text] [Related]
13. An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma.
Liu D; Zhou B; Liu R
PeerJ; 2020; 8():e9422. PubMed ID: 32742772
[TBL] [Abstract][Full Text] [Related]
14. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
15. Small Nucleolar RNAs: Insight Into Their Function in Cancer.
Liang J; Wen J; Huang Z; Chen XP; Zhang BX; Chu L
Front Oncol; 2019; 9():587. PubMed ID: 31338327
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
17. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
Wang Z; Tu L; Chen M; Tong S
BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
[TBL] [Abstract][Full Text] [Related]
18. Identification of Eight Small Nucleolar RNAs as Survival Biomarkers and Their Clinical Significance in Gastric Cancer.
Wang X; Xu M; Yan Y; Kuang Y; Li P; Zheng W; Liu H; Jia B
Front Oncol; 2019; 9():788. PubMed ID: 31552164
[TBL] [Abstract][Full Text] [Related]
19. Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer.
Zhu K; Liu X; Deng W; Wang G; Fu B
Hereditas; 2022 Feb; 159(1):13. PubMed ID: 35125116
[TBL] [Abstract][Full Text] [Related]
20. An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer.
Lian P; Wang Q; Zhao Y; Chen C; Sun X; Li H; Deng J; Zhang H; Ji Z; Zhang X; Huang Q
Aging (Albany NY); 2019 Sep; 11(17):6930-6940. PubMed ID: 31479417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
